Skip to main content
Caplight Logo









RocketVax AG

RocketVax AG

Private
BaselHealthcare & Life Scienceshttps://rocketvax.com/

Last Round

Seed

Dec 1, 2022

Total Funding Raised

$7.88M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

RocketVax AG is a biotechnology company that develops next-generation live-attenuated viral vaccines for infectious diseases, including COVID-19, cancer, and auto-immune disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

live-attenuated vaccineintranasal vaccinevaccine platformreverse genetic engineeringnasal spray vaccinevaccine developmentnext-gen vaccinesmucosal immunitypandemic preparednessclinical developmentbiotech R&Dinfectious disease preventionCDMOviral vectordrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RocketVax AG Comparables

Compare RocketVax AG with similar companies based on industry and business-model similarity.

RocketVax AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Codagenix
85%
Blue Lake Biotechnology, Inc.
80%
Vivaldi Biosciences, Inc.
79%

RocketVax AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 1, 2022
SeedAug 3, 2021
AcceleratorNov 10, 2020

Key People

Founding team and executive leadership

Vladimir Cmiljanovic

Founder, Vice-Chairman and CEO of Rocketvax AG

Founding Team

RocketVax AG Investors

Notable investors and investment history

RocketVax AG investors
InvestorRounds
Canton of Basel-StadtSeed
Ursimone Wietlisbach FoundationSeed
InnosuisseSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 356% MoM.

  • Apr 17, 2026

    Monthly visitors increased 42% MoM.

RocketVax AG Filings

Explore SEC and related filing metadata, where available.

RocketVax AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RocketVax AG's valuation, stock price, and market status.

Is RocketVax AG a public or private company?

RocketVax AG is a private company.

What is the current stock price of RocketVax AG?

RocketVax AG is a private company with no public stock price. Caplight tracks RocketVax AG's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is RocketVax AG worth (valuation)?

Valuation information for RocketVax AG is not publicly available.

Can I buy RocketVax AG stock?

RocketVax AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RocketVax AG's last funding round?

RocketVax AG's most recent funding round was Seed on December 1, 2022.

Who are the main investors in RocketVax AG?

Key investors in RocketVax AG include Ursimone Wietlisbach Foundation.

Will RocketVax AG IPO soon?

No public IPO plans have been announced for RocketVax AG.

How can I track RocketVax AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RocketVax AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBasel
Employee Range4
Year Founded2020
Last FundingDec 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?